Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.
JCI Insight
; 3(8)2018 04 19.
Article
in En
| MEDLINE
| ID: mdl-29669947
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Antigen, T-Cell
/
Immunotherapy, Adoptive
/
Antigens, CD19
/
Melphalan
/
Multiple Myeloma
Type of study:
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
JCI Insight
Year:
2018
Document type:
Article
Affiliation country:
United States
Country of publication:
United States